Reply to Letter to the Editor: “What Is the Optimal Antiplatelet Therapy in Type 2 Diabetes Mellitus Patients with Small Diameter Stents?”

Algazzar, Alaa S.; Aljondi, Raghad M.; Metwalli, Eilaf Majdi; Dhaher, Ghazal Y.; Mushaeb, Hanan H.; Aljadani, Renad H.; Balahmar, Rahaf S.; Hafiz, Awatif; Qutub, Mohamed A.

doi:10.14744/AnatolJCardiol.2025.5348

Letter to the Editor Reply

Reply to Letter to the Editor: “What Is the Optimal Antiplatelet Therapy in Type 2 Diabetes Mellitus Patients with Small Diameter Stents?”

Alaa S. Algazzar ¹

, Raghad M. Aljondi ²

, Eilaf Majdi Metwalli ²

, Ghazal Y. Dhaher ²

, Hanan H. Mushaeb ²

, Renad H. Aljadani ²

, Rahaf S. Balahmar ²

, Awatif Hafiz ³

, Mohamed A. Qutub ²

¹Department of Cardiology, Ahmed Maher Teaching Hospital, Cairo, Egypt
²Department of Medicine, King Abdulaziz University, Jeddah, Saudi Arabia
³Department of Pharmacy Practice, Faculty of Pharmacy, King Abdulaziz University, Jeddah, Saudi Arabia

Anatol J Cardiol 2025; 29(8): 450-451 PubMed ID: 40589136 DOI: 10.14744/AnatolJCardiol.2025.5348

Full Text PDF